Article summary
The rescheduling of cannabis by executive order and the FDA's acceleration of research into potential 5-MeO-DMT therapies reflects expanded federal support for clinical investigations into psychedelic-assisted treatments in the U.S. The post Federal Support for U.S. Psychedelic Research Accelerates 5-MeO-DMT Clinical Trials first appeared on Lucid News. The post Federal Support for U.S. Psychedelic Research Accelerates 5-MeO-DMT Clinical Trials appeared first on Lucid News.
Continue to the original publication for the complete article.